Allied Market Research
Platinum-based Drugs Market

Platinum-based Drugs Market

Size, Share, Competitive Landscape and Trend Analysis Report by Drug Type (Cisplatin     , Oxaliplatin, Carboplatin, Others), by Application (Colorectal Cancer, Ovarian Cancer, Lung Cancer, Others) and by End User (Hospitals, Drug Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A13436
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.


Prevalence of cancer has witnessed two-fold growth around the globe in recent years, owing to poor lifestyle, increased stress burdens, smocking & alcohol, and use of contraceptives in few cases. It is the second leading cause of global deaths, including lung cancer as the most potent one. Major symptoms of premature cancer include skin lump, changes in bowel, fatigue, and persistent cough. This enlightens the underlying need of design and development of new age effective therapies for cancer treatment. Under treatment procedure, primary treatment, adjuvant treatment, and palliative treatment form different arrays. Among primary treatment scenarios, surgeries and chemotherapies are the most effective techniques. Goal under surgery procedure is to completely remove cancer from the body.

Lately, platinum compounds have been at the fulcrum of cancer treatment especially ovarian cancer, bladder cancer, and testes cancer. The compounds have been known to crosslink with purine bases of the DNA, interfering with DNA mechanisms, causing DNA damage and gradually inducing apoptosis in the cancerous cells. Cisplatin is the most frequently used platinum drug for cancer treatment. It is a deep white or yellow or deep yellow in powder form at the room temperature. Cisplatin is shown to have cytotoxic properties, and is also used in combination with other cancer drugs as part of combination therapeutic strategy for various human cancers. Carboplatin, a derivative of cisplatin, is used to treat ovarian and lung cancer.

COVID-19 Impact Analysis

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the platinum based drugs market.

Top Impacting Factors

  • Decades of huge investments in medical science, biotechnology, and oncology for finding effective cancer treatment techniques, platinum drugs have become an integral part of cancer treatment and thus resulted in huge market gains.
  • A major growth driver of the carboplatin market is the ability of the drug to overcome grave security problems associated with other platinum-based drugs such as cisplatin.
  • Another major driver for growth of platinum drugs is the added capability of circumvent resistance, thus significantly increasing the clinical usefulness of these drugs. This includes drugs such as satraplatin, oxaliplatin, and picoplatin.
  • However, the major limitations associated with platinum drugs include adverse associated side effects and new age drug resistance capabilities of cancerous cells, downplaying the efficacy of drugs. These factors might restrain market growth in low-income economies.

Platinum based Drugs Market Trends

  • Emergence of analog drugs such as carrier molecule platinum complex against the drug resistance capabilities of cancerous cells is known to boost drug concentration inside cancer cells.
  • Cisplastin is widely shown to be an affective agent against testicular and ovarian cancers while being highly inefficient against other cancer types.
  • North America is anticipated to retain and gain higher chunk of market share, owing to increased disease prevalence, increased awareness about platinum drugs, intricately developed healthcare infrastructure, and surge in national disposable income.

Key Benefits of the Report

  • This study presents the analytical depiction of the platinum-based drugs industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the platinum-based drugs market share.
  • The current market is quantitatively analyzed to highlight the platinum based drugs market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the platinum based drugs market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Platinum-based Drugs Report

  • Which are the leading players active in the platinum based drugs market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the platinum based drugs market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the platinum based drugs market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 in the industry?
  • What is platinum based drugs ?
  • What is the platinum based drugs market prediction in the future?
  • What are the current trends and predicted trends?

Platinum-based Drugs Market Report Highlights

Aspects Details
By Drug Type
  • Cisplatin     
  • Oxaliplatin
  • Carboplatin
  • Others
By Application
  • Colorectal Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Others
By End User
  • Hospitals
  • Drug Clinics
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Teva Pharmaceutical Industries Ltd, Dr. Reddy’s Lab, Novartis AG, Accord Healthcare, SK Chemicals, Qilu Pharmaceuticals Ltd., Debiopharm Group, Ask-Pharma, Sun Pharma, Pfizer Inc

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Platinum-based Drugs Market

Start reading.
This Report and over 71,223+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690  $3,321
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930  $3,537
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820  $4,947
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540  $5,559
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870  $7,896
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports
*Terms and Conditions Apply

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save the time of readers